Fulcrum Equity Management’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-98,267
Closed -$3.25M 188
2021
Q1
$3.25M Buy
+98,267
New +$3.38M 1.29% 19

Other funds holding BOUT

Fulcrum Equity Management's BOUT Position: Q2 2021 in Review

Fulcrum Equity Management sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q2 2021, closing a stake of 98,267 shares — an estimated $3.25M sold.

Fulcrum Equity Management first reported a position in BOUT in Q1 2021 and held it in 1 quarter. The position peaked at $3.25M in Q1 2021. 11 funds tracked by Wall St. Rank hold BOUT as of Q2 2021.

  • Fulcrum Equity Management reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q2 2021 after selling out during the quarter.
  • Fulcrum Equity Management sold 98,267 CapForce IBD Breakout Opportunities ETF shares in Q2 2021, an estimated $3.25M.
  • Fulcrum Equity Management first reported a position in CapForce IBD Breakout Opportunities ETF in Q1 2021 and held it in 1 quarter.
  • Fulcrum Equity Management's CapForce IBD Breakout Opportunities ETF position peaked at $3.25M in Q1 2021.
  • 11 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2021.

Based on Fulcrum Equity Management's 13F filing for Q2 2021, filed 15 Jul 2021.